Short communicationLow blood–brain barrier permeability to azidothymidine (AZT), 3TC™, and thymidine in the rat
Section snippets
Acknowledgements
This study was supported by BioChem Pharma.
References (20)
- et al.
Independent blood–brain barrier transport systems for nucleic acid precursors
Biochim. Biophys. Acta
(1975) - et al.
Comparative distribution and whole-body autoradiographic distribution of [2-14C]azidodeoxythymidine and [2-14C]thymidine in mice
J. Pharmacol. Exp. Ther.
(1991) - et al.
Antiretroviral therapy for HIV infection in 1997
JAMA
(1997) - et al.
Microdialysis study of zidovudine (AZT) transport in rat brain
J. Pharamcol. Exp. Ther.
(1993) - et al.
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome
New Engl. J. Med.
(1985) - et al.
In vitro and in vivo transport of zidovudine (AZT) across the blood–brain barrier and the effect of transport inhibitors
Pharm. Res.
(1994) - et al.
HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease
FASEB J.
(1991) - et al.
The structure of HIV DNA in brain and blood of AIDS patients
Nature
(1990) - W.M. Pardridge, Peptide Drug Delivery to the Brain, Raven Press, New York, 1991, pp....
- et al.
Transport of steroid hormones through the rat blood–brain barrier. Primary role of albumin-bound hormone
J. Clin. Invest.
(1979)
Cited by (47)
Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery
2019, European Journal of Pharmaceutics and BiopharmaceuticsCitation Excerpt :This interplay is mediated by viral proteins gp120 and gp41, and host CD4 and chemokine receptors (CXCR4 or CCR5) [29]. Often hitchhiking on infected immune cells, HIV-1 is capable of crossing physiological barriers (e.g., the blood-brain barrier, the blood-testes barrier) and penetrating tissues (e.g., gut-associated lymphoid tissue, mucosa-associated lymphoid tissue and other lymphoid tissues) that are traditionally difficult to access with therapeutic agents [30–32]. The communication among the negatively charged amino acid residues of CXCR4, in the N-terminus and extracellular loops, is critical to the interaction with the positively charged amino acids of gp120 [33–35], as well as CXCL12 [36].
Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain
2014, Nanomedicine: Nanotechnology, Biology, and MedicineCitation Excerpt :The MDM amount was reduced non-significantly during the treatment period. The group treated with AZT demonstrated very low curative effect, evidently because of the poor drug penetration through the BBB.29 Thus, both AP-nano-AZT formulations demonstrated high efficacy in the suppression of HIV-1 activity in vivo.
How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability?
2011, European Journal of Pharmaceutical SciencesP-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model
2009, European Journal of Pharmaceutical SciencesProdrug and conjugate drug delivery strategies for improving HIV/AIDS therapy
2009, Journal of Drug Delivery Science and Technology